VICTORIA BANUELAS: Open Payments
NPI 1205561008 · RIVERSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,568 in 116 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $668 · 2025 $2,568
Food & beverage: $2,404Education: $164
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 11 | $472 |
| Amgen Inc. | 19 | $341 |
| ABBVIE INC. | 15 | $249 |
| UCB, Inc. | 13 | $236 |
| Regeneron Healthcare Solutions, Inc. | 5 | $213 |
| Novartis Pharmaceuticals Corporation | 9 | $189 |
| Janssen Biotech, Inc. | 6 | $152 |
| Galderma Laboratories, L.P. | 10 | $144 |
| Incyte Corporation | 9 | $141 |
| LEO Pharma Inc. | 5 | $106 |
Products named: DUPIXENT, Otezla, Bimzelx, SKYRIZI, COSENTYX, TREMFYA, NEMLUVIO, OPZELURA.
Industry payments across CA — which companies pay providers there.
